Omnicell, Inc. (OMCL) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $42.77 (+3.26%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Aug 11, 2025 | Jessica Tassan | Piper Sandler | $55.00 | +28.6% |
| May 14, 2025 | Stan Berenshteyn | Wells Fargo | $35.00 | -18.2% |
| Jan 13, 2025 | Stan Berenshteyn | Wells Fargo | $40.00 | -6.5% |
| Oct 31, 2024 | Stephanie Davis | Barclays | $58.00 | +35.6% |
| Aug 5, 2024 | Sean Wieland | Piper Sandler | $61.00 | +42.6% |
| Aug 2, 2024 | Stephanie Davis | Barclays | $39.00 | -8.8% |
| Aug 8, 2022 | Jessica Tassan | Piper Sandler | $150.00 | +250.7% |
| Jun 16, 2022 | Stan Berenshteyn | Wells Fargo | $158.00 | +269.4% |
Top Analysts Covering OMCL
OMCL vs Sector & Market
| Metric | OMCL | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.12 | 2.24 | 2.41 |
| Analyst Count | 8 | 8 | 18 |
| Target Upside | +33.7% | +1150.2% | +14.9% |
| P/E Ratio | 952.56 | 5.98 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.23B | $1.24B | $1.26B | 6 |
| 2027-03-31 | $311M | $317M | $323M | 2 |
| 2027-06-30 | $313M | $319M | $325M | 2 |
| 2027-09-30 | $322M | $329M | $335M | 2 |
| 2027-12-31 | $329M | $336M | $342M | 2 |
| 2028-03-31 | $339M | $346M | $352M | 1 |
| 2028-06-30 | $331M | $338M | $344M | 1 |
| 2028-09-30 | $355M | $363M | $369M | 1 |
| 2028-12-31 | $361M | $368M | $375M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.67 | $1.75 | $1.85 | 6 |
| 2027-03-31 | $0.35 | $0.35 | $0.36 | 1 |
| 2027-06-30 | $0.49 | $0.50 | $0.51 | 1 |
| 2027-09-30 | $0.54 | $0.56 | $0.57 | 1 |
| 2027-12-31 | $0.61 | $0.63 | $0.65 | 1 |
| 2028-03-31 | $0.37 | $0.38 | $0.39 | 2 |
| 2028-06-30 | $0.64 | $0.66 | $0.68 | 2 |
| 2028-09-30 | $0.70 | $0.72 | $0.74 | 2 |
| 2028-12-31 | $0.75 | $0.77 | $0.79 | 2 |
Frequently Asked Questions
What is the analyst consensus for OMCL?
The consensus among 8 analysts covering Omnicell, Inc. (OMCL) is Buy with an average price target of $55.25.
What is the highest price target for OMCL?
The highest price target for OMCL is $158.00, set by Stan Berenshteyn at Wells Fargo on 2022-06-16.
What is the lowest price target for OMCL?
The lowest price target for OMCL is $35.00, set by Stan Berenshteyn at Wells Fargo on 2025-05-14.
How many analysts cover OMCL?
8 analysts have issued ratings for Omnicell, Inc. in the past 12 months.
Is OMCL a buy or sell right now?
Based on 8 analyst ratings, OMCL has a consensus rating of Buy (2.12/5) with a +33.7% upside to the consensus target of $55.25.
What are the earnings estimates for OMCL?
Analysts estimate OMCL will report EPS of $1.75 for the period ending 2026-12-31, with revenue estimated at $1.24B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.